IBUPROFENE ZENTIVA LAB 400 mg, film-coated tablet 20 tablets
Active ingredients: Ibuprofen
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet20 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- IBUPROFENE ZENTIVA LAB 400 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC aluminium de 20 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 29 Apr 2024
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62434473CIP73024864CIP133400930248645Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IBUPROFÈNEcomprimé | 400 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.